Arthur Asirvatham

741 total citations
27 papers, 434 citations indexed

About

Arthur Asirvatham is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Arthur Asirvatham has authored 27 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Arthur Asirvatham's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Metabolism, Diabetes, and Cancer (6 papers). Arthur Asirvatham is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Metabolism, Diabetes, and Cancer (6 papers). Arthur Asirvatham collaborates with scholars based in India, United States and Singapore. Arthur Asirvatham's co-authors include Rajeev Gupta, Anuj Maheshwari, Sunil Gupta, Jitendra Kumar Singh, Vijay Achari, Prakash Deedwania, Arvind Gupta, Banshi Saboo, Rajiv Kumar Gupta and Soneil Guptha and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Drugs.

In The Last Decade

Arthur Asirvatham

22 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur Asirvatham India 9 247 115 77 69 53 27 434
Mohamadreza Neishaboury Iran 7 153 0.6× 77 0.7× 73 0.9× 38 0.6× 37 0.7× 20 389
Suraya Abdul-Razak Malaysia 12 140 0.6× 90 0.8× 60 0.8× 88 1.3× 20 0.4× 41 394
Pamela M Pelizzari United States 4 138 0.6× 167 1.5× 158 2.1× 98 1.4× 17 0.3× 5 469
Elangovan Nirmal India 4 212 0.9× 61 0.5× 42 0.5× 108 1.6× 19 0.4× 7 348
Usha Shrivastava India 10 317 1.3× 116 1.0× 147 1.9× 86 1.2× 28 0.5× 11 656
Lip Ping Low Singapore 7 121 0.5× 126 1.1× 76 1.0× 42 0.6× 28 0.5× 15 357
Abdullah M. Alguwaihes Saudi Arabia 12 261 1.1× 56 0.5× 53 0.7× 57 0.8× 49 0.9× 31 612
Wenzheng Sun China 14 97 0.4× 174 1.5× 129 1.7× 47 0.7× 43 0.8× 34 506
Xuxu Rao China 8 147 0.6× 197 1.7× 126 1.6× 82 1.2× 17 0.3× 19 413
M. Malik United Kingdom 7 170 0.7× 49 0.4× 148 1.9× 38 0.6× 30 0.6× 9 406

Countries citing papers authored by Arthur Asirvatham

Since Specialization
Citations

This map shows the geographic impact of Arthur Asirvatham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Asirvatham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Asirvatham more than expected).

Fields of papers citing papers by Arthur Asirvatham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Asirvatham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Asirvatham. The network helps show where Arthur Asirvatham may publish in the future.

Co-authorship network of co-authors of Arthur Asirvatham

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Asirvatham. A scholar is included among the top collaborators of Arthur Asirvatham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Asirvatham. Arthur Asirvatham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asirvatham, Arthur, et al.. (2025). Inhaled Insulin Decoded: Dispelling Myths and Presenting Clinical Evidence. Cureus. 17(12). e100247–e100247.
2.
Shaikh, Shehla, Surendra K. Sharma, Sanjeev Phatak, et al.. (2025). A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Study). Diabetes Therapy. 16(4). 645–661. 2 indexed citations
3.
4.
Asirvatham, Arthur, et al.. (2024). SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?. Journal of the Association of Physicians of India. 72(12). e35–e41. 1 indexed citations
5.
Jaggi, Shalini, et al.. (2023). Expert Opinion by Clinicians on the Use of Insulin Therapy in People with Hepatic Impairment. Journal of the Association of Physicians of India. 71(2). 78–85. 1 indexed citations
6.
Asirvatham, Arthur, et al.. (2023). Association of Killer Cell Immunoglobulin-Like Receptors and Their HLA-Ligands with Type 1 Diabetes Among South Indian Population. Immunological Investigations. 52(3). 270–285. 4 indexed citations
7.
8.
9.
10.
11.
12.
Asirvatham, Arthur, et al.. (2019). <i>SLC30A8</i> Gene rs13266634 C/T Polymorphism in Children with Type 1 Diabetes in Tamil Nadu, India. Journal of Clinical Research in Pediatric Endocrinology. 11(1). 55–60. 7 indexed citations
13.
Gupta, Rajeev, Krishna Kumar Sharma, Sailesh Lodha, et al.. (2018). Quality of Hypertension Management in Type 2 Diabetes in India: A Multisite Prescription Audit.. PubMed. 66(9). 20–25. 6 indexed citations
14.
Asirvatham, Arthur, et al.. (2017). Dose modification of antidiabetic agents in patients with type 2 diabetes mellitus and heart failure. Indian Journal of Endocrinology and Metabolism. 21(4). 618–618. 3 indexed citations
15.
Shakila, Harshavardhan, et al.. (2017). MTHFR C677T gene polymorphism in Type 2 diabetes mellitus patients with and without vascular complications: A case-control study. Meta Gene. 14. 79–84. 3 indexed citations
16.
Mohan, Viswanathan, Sanjay Kalra, Jothydev Kesavadev, et al.. (2017). Consensus on Initiation and Intensification of Premix Insulin in Type 2 Diabetes Management.. PubMed. 65(4). 59–73. 12 indexed citations
17.
Asirvatham, Arthur, et al.. (2014). Analysis of DNA damage, plasma lipid peroxidation, and antioxidant status in type 2 diabetes mellitus patients among a south Indian population. International Journal of Diabetes in Developing Countries. 35(S3). 491–495. 1 indexed citations
18.
Gupta, Rajeev, Rajeev Gupta, Prakash Deedwania, et al.. (2012). Association of Educational, Occupational and Socioeconomic Status with Cardiovascular Risk Factors in Asian Indians: A Cross-Sectional Study. PLoS ONE. 7(8). e44098–e44098. 103 indexed citations
19.
Gupta, Rajeev, Prakash Deedwania, Vijay Achari, et al.. (2012). Normotension, Prehypertension, and Hypertension in Urban Middle-Class Subjects in India: Prevalence, Awareness, Treatment, and Control. American Journal of Hypertension. 26(1). 83–94. 63 indexed citations
20.
Asirvatham, Arthur, et al.. (2011). Endothelial Nitric Oxide Synthase Gene Polymorphism (G894T) and Diabetes Mellitus (Type II) among South Indians. Oxidative Medicine and Cellular Longevity. 2011. 1–4. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamadreza Neishaboury Breakdown of academic impact, for papers by Suraya Abdul-Razak Breakdown of academic impact, for papers by Pamela M Pelizzari Breakdown of academic impact, for papers by Elangovan Nirmal Breakdown of academic impact, for papers by Usha Shrivastava Breakdown of academic impact, for papers by Lip Ping Low Breakdown of academic impact, for papers by Abdullah M. Alguwaihes Breakdown of academic impact, for papers by Wenzheng Sun Breakdown of academic impact, for papers by Xuxu Rao Breakdown of academic impact, for papers by M. Malik
Rankless by CCL
2026